echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Cheer up! Shanghai decides to give priority to the development of biomedical industry! Implemented on September 1!

    Cheer up! Shanghai decides to give priority to the development of biomedical industry! Implemented on September 1!

    • Last Update: 2017-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Translational Medicine Network August 29, 2017, the general office of Shanghai Municipal People's government officially released the implementation opinions on promoting the healthy development of the biomedical industry in this city It is clear in the paper that priority should be given to the development of biological products, and the research on technologies related to immunotherapy, stem cells and gene therapy should be accelerated In the implementation opinions on promoting the healthy development of biomedical industry in Shanghai (hereinafter referred to as the Implementation Opinions), Shanghai Municipal People's government clearly proposed to give priority to the development of biological products, focusing on promoting the development of immunosuppressive checkpoint inhibitors, antibody coupled drugs, new vaccines, protein and polypeptide biological drugs, and accelerating the development of immunotherapy, stem cells and gene therapy Relevant technical research We will actively promote the industrialization of anti-tumor drugs, break through a number of key core technologies such as large-scale antibody cultivation, localization of production equipment and supporting products, and drive the rapid development of Shanghai's biopharmaceutical industry In the implementation opinions, it is also proposed to promote third-party R & D and production services We will optimize the allocation of medical service resources, and encourage the development of independent third-party medical institutions such as clinical laboratories, medical imaging and pathological diagnosis For precision medicine and intelligent medical services, the implementation opinions proposes to actively promote the construction of medical big data application technology in the National Engineering Laboratory, and develop a number of mobile network-based remote diagnosis and treatment equipment and related software with intelligent perception and remote communication functions around the application fields of health management and disease early warning monitoring, monitoring, screening, diagnosis and treatment rehabilitation A number of high-performance medical wearable devices for in vitro diagnosis were developed At the same time, the implementation opinions put forward to strengthen financial support Actively guide social capital to build a platform for biomedical research and development, financing and transformation, and give full play to the leverage of special funds such as strategic emerging industry development In terms of the overall goal, the implementation opinions put forward: further improve the construction of medical product management, quality, standard and registration system, improve the quality of industrial development; promote the development of manufacturing industry to biopharmaceutical, high-end preparations and high-end medical devices; build transformation medical research center.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.